Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson’s Disease (PD) Symptoms and Biomarkers (MCT-PD)
Condition(s):Parkinson’s DiseaseLast Updated:September 13, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:September 13, 2022Completed
Condition(s):Knee Osteoarthritis; Disuse AtrophyLast Updated:July 21, 2014Completed
Condition(s):Multiple SclerosisLast Updated:April 8, 2011Completed
Condition(s):Progressive Supranuclear Palsy; Cognitive ImpairmentLast Updated:March 27, 2018Completed
Condition(s):Fatigue; Cardiopulmonary Arrest; Physical Inactivity; Muscle Weakness; Stress, Emotional; DyspneaLast Updated:April 5, 2023Not yet recruiting
Condition(s):Parkinson’s Disease; Deep Brain Stimulation; Gait Disorders, NeurologicLast Updated:June 15, 2023Recruiting
Condition(s):StrokeLast Updated:March 22, 2022Completed
Condition(s):StrokeLast Updated:April 3, 2020Completed
Condition(s):Activity, Motor; Elderly Patients; Musculoskeletal DiseasesLast Updated:March 12, 2024Completed
Condition(s):Parkinson Disease; Freezing of Gait; Split-belt TreadmillLast Updated:February 7, 2024Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.